Terms ending in 2032
Every in-force patent on Bionomics Limited's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,062,013 | Positive Allosteric Modulators of the Alpha 7 Nicotinic Acetylcholine Receptor and Uses Thereof In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 9,133,188 | Methods for Preparing Naphthyridines In force · High confidence | Bionomics Limited | In force | High confidence | |
| US 9,220,774 | Methods of Treating Cancer by Administering ANTI-GPR49 Antibodies In force · High confidence | Bionomics Inc. | In force | High confidence | |
| US 9,221,906 | Methods of Inhibiting Solid Tumor Growth by Administering GPR49 Antibodies In force · High confidence | Bionomics Inc. | In force | High confidence | |
| US 9,221,907 | ANTI-GPR49 Monoclonal Antibodies In force · High confidence | Bionomics Inc. | In force | High confidence | |
| US 10,196,442 | Methods of Inhibiting Growth of a Colon Cancer Tumor in a Subject by Administering Monoclonal Antibodies to G Protein-Coupled Receptor 49 (GPR49) In force · High confidence | Bionomics Inc. | In force | High confidence | |
| US 10,598,653 | Methods of Blocking Cancer Stem Cell Growth In force · High confidence | Bionomics Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
6 of these are in force and held by Bionomics Limited.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.